1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
- 2006
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
- 2005
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
- 2002
-
Mark
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
(
- Contribution to journal › Article